Leukemia inhibitory factor receptor (LIFR) is a signal-transducing molecule. LIFR may have a common pathway with IL6ST. The soluble form of LIFR inhibits the biological activity of LIF by blocking its binding to receptors on target cells [taken from the Universal Protein Resource (UniProt) www.uniprot.org/uniprot/P42702].
